CSPC Pharmaceutical Publishes 2026 Interim Report Online; Shareholders May Request Printed Copies

Bulletin Express

Sep 17

CSPC Pharmaceutical Group Limited announced on 18 September 2026 that its 2026 Interim Report is now available in both English and Chinese on the company’s website (www.cspc.com.hk) and on the Hong Kong Stock Exchange’s HKEXnews portal (www.hkexnews.hk).

Non-registered shareholders—those holding shares through the Central Clearing and Settlement System (CCASS)—can obtain the interim report and all future corporate communications in printed form by submitting a completed Request Form to the company’s share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. For responses mailed within Hong Kong, the enclosed postage-paid mailing label may be used; overseas mailings require appropriate postage.

Enquiries can be directed to the company hotline at (852) 2980 1333, Monday to Friday between 9:00 a.m. and 5:00 p.m. The notification was issued by Company Secretary Lo Tai On on behalf of CSPC Pharmaceutical Group.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/news/1136211714"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136211714\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136211714?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 18:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136211714","market":"us","top_or_hot":-1,"title":"CSPC Pharmaceutical Publishes 2026 Interim Report Online; Shareholders May Request Printed Copies","media":"Bulletin Express","content":"<p>CSPC Pharmaceutical Group Limited announced on 18 September 2026 that its 2026 Interim Report is now available in both English and Chinese on the company’s website (www.cspc.com.hk) and on the Hong Kong Stock Exchange’s HKEXnews portal (www.hkexnews.hk).</p>\n<p>Non-registered shareholders—those holding shares through the Central Clearing and Settlement System (CCASS)—can obtain the interim report and all future corporate communications in printed form by submitting a completed Request Form to the company’s share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. For responses mailed within Hong Kong, the enclosed postage-paid mailing label may be used; overseas mailings require appropriate postage.</p>\n<p>Enquiries can be directed to the company hotline at (852) 2980 1333, Monday to Friday between 9:00 a.m. and 5:00 p.m. The notification was issued by Company Secretary Lo Tai On on behalf of CSPC Pharmaceutical Group.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CSPC Pharmaceutical Publishes 2026 Interim Report Online; Shareholders May Request Printed Copies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCSPC Pharmaceutical Publishes 2026 Interim Report Online; Shareholders May Request Printed Copies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-17 18:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CSPC Pharmaceutical Group Limited announced on 18 September 2026 that its 2026 Interim Report is now available in both English and Chinese on the company’s website (www.cspc.com.hk) and on the Hong Kong Stock Exchange’s HKEXnews portal (www.hkexnews.hk).</p>\n<p>Non-registered shareholders—those holding shares through the Central Clearing and Settlement System (CCASS)—can obtain the interim report and all future corporate communications in printed form by submitting a completed Request Form to the company’s share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. For responses mailed within Hong Kong, the enclosed postage-paid mailing label may be used; overseas mailings require appropriate postage.</p>\n<p>Enquiries can be directed to the company hotline at (852) 2980 1333, Monday to Friday between 9:00 a.m. and 5:00 p.m. The notification was issued by Company Secretary Lo Tai On on behalf of CSPC Pharmaceutical Group.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01093","symbol_name":"石药集团","start_time":0,"source_url":"","article_id":"1136211714","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136211714","pubTimestamp":1789640509,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CSPC Pharmaceutical Group Limited announced on 18 September 2026 that its 2026 Interim Report is now available in both English and Chinese on the company’s website (www.cspc.com.hk) and on the Hong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01093":"石药集团"},"translate_title":"石药制药在线发布2026年中期报告；股东可索取印刷本","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1},"content_text":"CSPC Pharmaceutical Group Limited announced on 18 September 2026 that its 2026 Interim Report is now available in both English and Chinese on the company’s website (www.cspc.com.hk) and on the Hong Kong Stock Exchange’s HKEXnews portal (www.hkexnews.hk).\nNon-registered shareholders—those holding shares through the Central Clearing and Settlement System (CCASS)—can obtain the interim report and all future corporate communications in printed form by submitting a completed Request Form to the company’s share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. For responses mailed within Hong Kong, the enclosed postage-paid mailing label may be used; overseas mailings require appropriate postage.\nEnquiries can be directed to the company hotline at (852) 2980 1333, Monday to Friday between 9:00 a.m. and 5:00 p.m. The notification was issued by Company Secretary Lo Tai On on behalf of CSPC Pharmaceutical Group.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}